Your browser doesn't support javascript.
loading
Characterization of the Interaction Between SARS-CoV-2 Membrane Protein (M) and Proliferating Cell Nuclear Antigen (PCNA) as a Potential Therapeutic Target.
Zambalde, Érika Pereira; Pavan, Isadora Carolina Betim; Mancini, Mariana Camargo Silva; Severino, Matheus Brandemarte; Scudero, Orlando Bonito; Morelli, Ana Paula; Amorim, Mariene Ribeiro; Bispo-Dos-Santos, Karina; Góis, Mariana Marcela; Toledo-Teixeira, Daniel A; Parise, Pierina Lorencini; Mauad, Thais; Dolhnikoff, Marisa; Saldiva, Paulo Hilário Nascimento; Marques-Souza, Henrique; Proenca-Modena, José Luiz; Ventura, Armando Morais; Simabuco, Fernando Moreira.
Afiliação
  • Zambalde ÉP; Multidisciplinary Laboratory of Food and Health, School of Applied Sciences, University of Campinas (Unicamp), Limeira, Brazil.
  • Pavan ICB; Laboratory of Signaling Mechanisms, School of Pharmaceutical Sciences, University of Campinas, (Unicamp), Campinas, Brazil.
  • Mancini MCS; Multidisciplinary Laboratory of Food and Health, School of Applied Sciences, University of Campinas (Unicamp), Limeira, Brazil.
  • Severino MB; Multidisciplinary Laboratory of Food and Health, School of Applied Sciences, University of Campinas (Unicamp), Limeira, Brazil.
  • Scudero OB; Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil.
  • Morelli AP; Multidisciplinary Laboratory of Food and Health, School of Applied Sciences, University of Campinas (Unicamp), Limeira, Brazil.
  • Amorim MR; Laboratory of Emerging Viruses (LEVE), Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas (Unicamp), Campinas, SP, Brazil.
  • Bispo-Dos-Santos K; Laboratory of Emerging Viruses (LEVE), Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas (Unicamp), Campinas, SP, Brazil.
  • Góis MM; Multidisciplinary Laboratory of Food and Health, School of Applied Sciences, University of Campinas (Unicamp), Limeira, Brazil.
  • Toledo-Teixeira DA; Laboratory of Emerging Viruses (LEVE), Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas (Unicamp), Campinas, SP, Brazil.
  • Parise PL; Laboratory of Emerging Viruses (LEVE), Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas (Unicamp), Campinas, SP, Brazil.
  • Mauad T; São Paulo University Medical School, Department of Pathology, University of São Paulo (USP), São Paulo, Brazil.
  • Dolhnikoff M; São Paulo University Medical School, Department of Pathology, University of São Paulo (USP), São Paulo, Brazil.
  • Saldiva PHN; São Paulo University Medical School, Department of Pathology, University of São Paulo (USP), São Paulo, Brazil.
  • Marques-Souza H; Institute of Biology, University of Campinas (Unicamp), Campinas, SP, Brazil.
  • Proenca-Modena JL; Laboratory of Emerging Viruses (LEVE), Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas (Unicamp), Campinas, SP, Brazil.
  • Ventura AM; Experimental Medicine Research Cluster, University of Campinas (Unicamp), Campinas, Brazil.
  • Simabuco FM; Hub of Global Health (HGH), University of Campinas (Unicamp), Campinas, Brazil.
Front Cell Infect Microbiol ; 12: 849017, 2022.
Article em En | MEDLINE | ID: mdl-35677658
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno Nuclear de Célula em Proliferação / Proteínas M de Coronavírus / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno Nuclear de Célula em Proliferação / Proteínas M de Coronavírus / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Suíça